Xanum C.L. is an enterprise in Ecuador, with the main office in Samborondon. The company operates in the Pharmaceutical and Medicine Manufacturing sector. The enterprise was incorporated on September 01, 2017. It currently has a total number of 4 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue drop of 64.18% in 2025. Its’ total assets recorded a negative growth of 16.33%. In 2025, Xanum C.L.’s net profit margin increased by 4.49%.

Headquarters
There is no available data
Samborondon; Guayas;

Contact Details: Purchase the Xanum C.L. report to view the information.

Basic Information

Total Employees:

Purchase the Xanum C.L. report to view the information.

Registered Capital:

Purchase the Xanum C.L. report to view the information.

Financial Auditors:

Purchase the Xanum C.L. report to view the information.

Incorporation Date:

September 01, 2017

Key Executives

Purchase this report to view the information.

President

Ownership Details

Purchase this report to view the information.

100%

Company Performance

Financial values in the chart are available after Xanum C.L. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.

Net sales revenue

-64.18%▼

Total Operating Revenue

-64.8%▼

Operating Profit

-60.41%▼

EBITDA

-50.49%▼

Net Profit/Loss for the Period

-28.5%▼

Total Assets

-16.33%▼

Total Equity

2.61%▲

Operating Profit Margin

1.89%▲

Net Profit Margin

4.49%▲

Return on Equity (ROE)

-1.11%▼

Debt / Equity

-24.36%▼

Quick Ratio

1.82%▲

Xanum C.L. (Ecuador)

Similar companies

Related EMIS Industry Reports